In this episode of the Diabetes Innovators Series, the conversation explores the evolution of diabetes treatment, the challenges faced in managing diabetes today, and the future of diabetes research. Zan, an endocrinologist and former FDA executive and Founder and executive chairman of Kinexum, shares insights from his career, including the historical context of diabetes management, the importance of A1C as a marker, and the potential of new treatments like GLP-1 agonists. The discussion also touches on the concept of meta-abesity, the shared root causes of chronic diseases, and the need for a focus on health span rather than just lifespan.
Chapters
00:00 Introduction to Diabetes Innovation Series
03:06 Zan's Journey in Diabetes Research
06:05 Transforming Diabetes Treatment: A Historical Perspective
09:00 The Evolution of Diabetes Management Tools
11:42 Challenges in Diabetes Management Today
14:41 The Future of Diabetes Treatment: Aiming for a Cure
17:57 Understanding the Drug Approval Process
20:32 Meta-Abesity: A New Perspective on Chronic Diseases
23:48 Innovations in Longevity and Health Span
26:27 The Role of GLP-1 Agonists in Diabetes Management
29:29 Future Directions in Diabetes Research
32:29 Memorable Moments in Drug Proposals
35:37 Conclusion and Future Collaborations
Resources:
